RedHill Biopharma (RDHL) Posts Q1 Loss of 5c/Share

RedHill Biopharma (NASDAQ: RDHL) reported Q1 EPS of ($0.05), $0.42 better than the analyst estimate of ($0.47).

For earnings history and earnings-related data on RedHill Biopharma (RDHL) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Cerebras Systems posts 94% revenue jump, announces OpenAI deal
• After-Hours Stock Movers: FDX, CBRS, NKE